Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative... by Cartron, Guillaume, Letestu, Rémi, Dartigeas, Caroline, Tout, Mira, Mahé, Béatrice, Gagez, Anne-Laure, Ferrant, Emmanuelle, Guiu, Boris, Villemagne, Bruno, Letuan, Phan, Aurran, Thérèse, Orsini-Piocelle, Frédérique, Banos, Anne, Feugier, Pierre, Leblond, Véronique, de Guibert, Sophie, Tournilhac, Olivier, Dupuis, Jehan, Delmer, Alain, Rouillé, Valérie, Ternant, David, Leprêtre, Stéphane

Get full text

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-lab... by Vano, Yann-Alexandre, Elaidi, Réza, Bennamoun, Mostefa, Chevreau, Christine, Borchiellini, Delphine, Pannier, Diane, Maillet, Denis, Gross-Goupil, Marine, Tournigand, Christophe, Laguerre, Brigitte, Barthélémy, Philippe, Coquan, Elodie, Gravis, Gwenaëlle, Houede, Nadine, Cancel, Mathilde, Huillard, Olivier, Beuzeboc, Philippe, Fournier, Laure, Méjean, Arnaud, Cathelineau, Xavier, Doumerc, Nicolas, Paparel, Philippe, Bernhard, Jean-Christophe, de la Taille, Alexandre, Bensalah, Karim, Tricard, Thibault, Waeckel, Thibaut, Pignot, Géraldine, Braychenko, Elena, Caruso, Stefano, Sun, Cheng-Ming, Verkarre, Virginie, Lacroix, Guillaume, Moreira, Marco, Meylan, Maxime, Bougouïn, Antoine, Phan, Letuan, Thibault-Carpentier, Christelle, Zucman-Rossi, Jessica, Fridman, Wolf Herman, Sautès-Fridman, Catherine, Oudard, Stéphane

Get full text

Optimal molecular selection to benefit from nivolumab–ipilimumab in clear-cell renal cell carcinoma by Vano, Yann-Alexandre, Elaidi, Réza, Phan, Letuan, Fridman, Wolf Herman, Sautès-Fridman, Catherine, Oudard, Stéphane

Get full text

How molecularly similar are primary and metastatic tissues in renal cell carcinoma? – Authors’ reply by Vano, Yann-Alexandre, Elaidi, Réza, Phan, Letuan, Meylan, Maxime, Fridman, Wolf Herman, Sautès-Fridman, Catherine, Oudard, Stéphane

Get full text

Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis by Elaidi, Reza, Phan, Letuan, Borchiellini, Delphine, Barthelemy, Philippe, Ravaud, Alain, Oudard, Stéphane, Vano, Yann

Get full text

Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma by Benhamouda, Nadine, Sam, Ikuan, Epaillard, Nicolas, Gey, Alain, Phan, Letuan, Pham, Hang Phuong, Gruel, Nadège, Saldmann, Antonin, Pineau, Joséphine, Hasan, Milena, Quiniou, Valentin, Nevoret, Camille, Verkarre, Virginie, Libri, Valentina, Mella, Sebastien, Granier, Clémence, Broudin, Chloe, Ravel, Patrice, De Guillebon, Eléonore, Mauge, Laetitia, Helley, Dominique, Jabla, Bernd, Chaput, Nathalie, Albiges, Laurence, Katsahian, Sandrine, Adam, Julien, Mejean, Arnaud, Adotevi, Olivier, Vano, Yann A, Oudard, Stéphane, Tartour, Eric

Get full text

Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study by Vano, Yann‐Alexandre, Phan, Letuan, Gravis, Gwenaelle, Korakis, Iphigénie, Schlürmann, Friederike, Maillet, Denis, Bennamoun, Mostefa, Houede, Nadine, Topart, Delphine, Borchiellini, Delphine, Barthelemy, Philippe, Ratta, Raffaele, Ryckewaert, Thomas, Hasbini, Ali, Hans, Sophie, Emambux, Sheik, Cournier, Sandra, Braychenko, Elena, Elaidi, Réza‐Thierry, Oudard, Stéphane

Get full text

Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study by Vano, Yann‐alexandre, Phan, Letuan, Gravis, Gwenaelle, Korakis, Iphigénie, Schlürmann, Friederike, Maillet, Denis, Bennamoun, Mostefa, Houédé, Nadine, Topart, Delphine, Borchiellini, Delphine, Barthelemy, Philippe, Ratta, Raffaele, Ryckewaert, Thomas, Hasbini, Ali, Hans, Sophie, Emambux, Sheik, Cournier, Sandra, Braychenko, Elena, Elaidi, Réza‐thierry, Oudard, Stéphane

Get full text

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-lab... by Vano, Yann-Alexandre, Elaidi, Réza, Bennamoun, Mostefa, Chevreau, Christine, Borchiellini, Delphine, Pannier, Diane, Maillet, Denis, Gross-Goupil, Marine, Tournigand, Christophe, Laguerre, Brigitte, Barthélémy, Philippe, Coquan, Elodie, Gravis, Gwenaëlle, Houede, Nadine, Cancel, Mathilde, Huillard, Olivier, Beuzeboc, Philippe, Fournier, Laure, Méjean, Arnaud, Cathelineau, Xavier, Doumerc, Nicolas, Paparel, Philippe, Bernhard, Jean-Christophe, de la Taille, Alexandre, Bensalah, Karim, Tricard, Thibault, Waeckel, Thibaut, Pignot, Géraldine, Braychenko, Elena, Caruso, Stefano, Sun, Cheng-Ming, Verkarre, Virginie, Lacroix, Guillaume, Moreira, Marco, Meylan, Maxime, Bougouïn, Antoine, Phan, Letuan, Thibault-Carpentier, Christelle, Zucman-Rossi, Jessica, Fridman, Wolf Herman, Sautès-Fridman, Catherine, Oudard, Stéphane

Get full text